Systematic Review of Prevalence of Histoplasma Antigenuria in Persons with HIV in Latin America and Africa

Preethiya Sekar, Gila Hale, Jane Gakuru, David B. Meya, David R. Boulware, Jayne Ellis, Elizabeth Nalintya, Nathan C. Bahr, Radha Rajasingham

Research output: Contribution to journalArticlepeer-review

Abstract

Histoplasmosis is a fungal disease associated with substantial mortality rates among persons with advanced HIV disease. Our systematic review synthesized data on the global prevalence of Histoplasma-caused antigenuria in persons with HIV. We searched PubMed/ Medline, Embase, and Scopus databases on January 3, 2023, to identify cross-sectional and cohort studies evaluating Histoplasma antigenuria prevalence among adults with HIV infection. We calculated point estimates and 95% CIs to summarize prevalence. Of 1,294 studies screened, we included 15. We found Histoplasma antigenuria among 581/5,096 (11%; 95% CI 11%–12%) persons with HIV and 483/3,789 persons with advanced HIV disease (13%; 95% CI 12%–14%). Among persons with HIV and symptoms consistent with histoplasmosis, Histoplasma antigenuria prevalence was 14% (95% CI 13%–15%; 502/3,631 participants). We determined that persons with advanced HIV disease, inpatients, and symptomatic persons might benefit from a systematic approach to early detection of histoplasmosis using urine antigen testing.

Original languageEnglish (US)
Pages (from-to)1523-1530
Number of pages8
JournalEmerging infectious diseases
Volume30
Issue number8
DOIs
StatePublished - Aug 2024

Bibliographical note

Publisher Copyright:
© 2024 Centers for Disease Control and Prevention (CDC). All rights reserved.

PubMed: MeSH publication types

  • Systematic Review
  • Journal Article
  • Review

Fingerprint

Dive into the research topics of 'Systematic Review of Prevalence of Histoplasma Antigenuria in Persons with HIV in Latin America and Africa'. Together they form a unique fingerprint.

Cite this